State Board of Administration of Florida Retirement System’s UroGen Pharma URGN Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,641	Closed	-$136K	–	2413
2022 Q1	$136K	Hold	15,641	–	–	﹤0.01%	2234
2021 Q4	$149K	Hold	15,641	–	–	﹤0.01%	2271
2021 Q3	$263K	Hold	15,641	–	–	﹤0.01%	2154
2021 Q2	$239K	Buy	+15,641	New	+$283K	﹤0.01%	2222
2020 Q1	–	Sell	-6,570	Closed	-$219K	–	2285
2019 Q4	$219K	Buy	+6,570	New	+$179K	﹤0.01%	2094
2019 Q3	–	Sell	-6,570	Closed	-$236K	–	2280
2019 Q2	$236K	Buy	+6,570	New	+$242K	﹤0.01%	2064

Other funds holding URGN

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Board of Administration of Florida Retirement System's URGN Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of UroGen Pharma (URGN) in Q2 2022, closing a stake of 15,641 shares — an estimated $136K sold.

State Board of Administration of Florida Retirement System first reported a position in URGN in Q2 2019 and held it in 6 quarters. The position peaked at $263K in Q3 2021. 65 funds tracked by Wall St. Rank hold URGN as of Q2 2022.

State Board of Administration of Florida Retirement System reported no remaining UroGen Pharma position as of Q2 2022 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 15,641 UroGen Pharma shares in Q2 2022, an estimated $136K.
State Board of Administration of Florida Retirement System first reported a position in UroGen Pharma in Q2 2019 and held it in 6 quarters.
State Board of Administration of Florida Retirement System's UroGen Pharma position peaked at $263K in Q3 2021.
65 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.